"After recently signing two contracts with UK pharmaceutical companies for our EU-GMP pharmaceutical cannabis products, and with a strong pipeline of enquiries about new commercial contracts the Company has taken the opportunity to secure £1.0m of additional working capital" #CEL pic.twitter.com/us6aGBoWKY
— Celadon Pharmaceuticals PLC (@CeladonPlc) October 13, 2023
Sign up for our daily Newsletter and stay up to date with all the latest news!
Subscribe I am already a subscriber